CDKN2A (p16INK4A) somatic and germline mutations

Human Mutation

Volumn 7, Issue 4, 1996, Pages 294-303

  Smith Sørensen, Birgitte ^a   Hovig, Eivind ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

CDKN2A gene; Database; Proteins

Indexed keywords

CYCLIN DEPENDENT KINASE; CARRIER PROTEIN; PROTEIN P16INK4A;

ARTICLE; BLADDER CANCER; CELL CYCLE; DATA BASE; DIGESTIVE SYSTEM CANCER; FAMILIAL CANCER; GENE MAPPING; GENE MUTATION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; LUNG CANCER; MAMMAL CELL; MELANOMA; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE; GENETICS; MUTATION; NEOPLASM; REVIEW;

CARRIER PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; GERM-LINE MUTATION; HUMANS; MUTATION; NEOPLASMS;

EID: 0029715628     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1098-1004(1996)7:4<294::aid-humu2>3.3.co;2-i     Document Type: Article

References (13)

1. Berns E, Klijn J, Smid M, Van SI, Gruis NA, Foekens JA (1995) Infrequent CDKN2 (MTS1/p16) gene alterations in human primary breast cancer. Br J Cancer 72:964-967.
2. Blanquet V, Turleau C, Gross-Morand MS, Senamaud-Beaufort C, Doz F, Besmond C (1995) Spectrum of germline mutations in the RB1 gene: A study of 232 patients with hereditary and non hereditary retinoblastoma. Hum Mol Genet 4:383-388.
3. Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP, Halperin AJ, Ponten J (1991) A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 88:10124-10128.
4. Brenner AJ, Aldaz CM (1995) Chromosome 9p allelic loss and p16/CDKN2 in breast cancer and evidence of p16 inactivation in immortal breast epithelial cells. Cancer Research 55:2892-2895.
5. Cairns P, Shaw ME, Knowles MA, Grana X, Reddy EP (1993) Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9. Cell cycle control in mammalian cells: Role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 8:1083-1085.
6. Cairns P, Mao L, Merlo A, Lee DJ, Schwab D, Eby Y, Tokino K, van der Riet P, Blaugrund JE, Sidransky D (1994a) Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science 265:415-417.
7. Cairns P, Tokino K, Eby Y, Sidransky D (1994b) Homozygous deletions of 9p21 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction. Cancer Res 54:1422-1424.
8. Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ, Kern SE (1994) Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nature Genet 8:27-32.
9. Cannon-Albright LA, Goldgar DE, Meyer LJ, Lewis CM, Anderson DE, Fountain JW, Hegi ME, Wiseman RW, Petty EM, Bale AE et al. (1992) Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. Science 258:1148-1152.
10. Yeudall WA, Crawford RY, Ensley JF, Robbins KG (1994) MTS1/CDK41 is altered in cell lines derived from primary and metastatic oral squamous cell carcinoma. Carcinogenesis 15:2683-2686.
11. Yoshida S, Todoroki T, Ichikawa Y, Hanai S, Suzuki H, Hori M, Fukao K, Miwa M, Uchida K (1995) Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers. Cancer Res 55:2756-2760.
12. Zhang SY, Klein-Szanto AJ, Sauter ER, Shafarenko M, Mitsunaga S, Nobori T, Carson DA, Ridge JA, Goodrow TL (1994) Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. Cancer Res 54:5050-5053.
13. Zhou X, Tarmin L, Yin J, Jiang HY, Suzuki H, Rhyu MG, Abraham JM, Meltzer SJ (1994) The MTS1 gene is frequently mutated in primary human esophageal tumors. Oncogene 9:3737-3741.